Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis.

Marinò M, Chiovato L, Friedlander JA, Latrofa F, Pinchera A, McCluskey RT.

J Clin Endocrinol Metab. 1999 Jul;84(7):2468-74.

PMID:
10404822
2.

Circulating thyroglobulin transcytosed by thyroid cells in complexed with secretory components of its endocytic receptor megalin.

Marinò M, Chiovato L, Mitsiades N, Latrofa F, Andrews D, Tseleni-Balafouta S, Collins AB, Pinchera A, McCluskey RT.

J Clin Endocrinol Metab. 2000 Sep;85(9):3458-67.

PMID:
10999849
3.

Megalin (gp330) is an endocytic receptor for thyroglobulin on cultured fisher rat thyroid cells.

Marinò M, Zheng G, McCluskey RT.

J Biol Chem. 1999 Apr 30;274(18):12898-904.

4.

Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease.

Antonelli A, Fallahi P, Nesti C, Pupilli C, Marchetti P, Takasawa S, Okamoto H, Ferrannini E.

Clin Exp Immunol. 2001 Dec;126(3):426-31.

5.

Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.

Hopf U, Fiek T, Grün R, Zuschneid W.

J Clin Lab Immunol. 1982 Oct;9(1):49-53.

PMID:
6757440
8.

Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.

Gunji K, De Bellis A, Li AW, Yamada M, Kubota S, Ackrell B, Wengrowicz S, Bellastella A, Bizzarro A, Sinisi A, Wall JR.

J Clin Endocrinol Metab. 2000 Apr;85(4):1641-7.

PMID:
10770210
9.

Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.

Ochi Y, Hamazu M, Kajita Y, Nagata A.

Clin Endocrinol (Oxf). 2002 Mar;56(3):405-12.

PMID:
11940054
10.

Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.

Macchia E, Concetti R, Borgoni F, Cetani F, Fenzi GF, Pinchera A.

Autoimmunity. 1989;3(2):103-12.

PMID:
2577491
11.

Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease.

Bogner U, Schleusener H, Wall JR.

J Clin Endocrinol Metab. 1984 Oct;59(4):734-8.

PMID:
6548225
12.

Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.

Kerjaschki D, Exner M, Ullrich R, Susani M, Curtiss LK, Witztum JL, Farquhar MG, Orlando RA.

J Clin Invest. 1997 Nov 1;100(9):2303-9.

14.

Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.

Ajjan RA, Kemp EH, Waterman EA, Watson PF, Endo T, Onaya T, Weetman AP.

J Clin Endocrinol Metab. 2000 May;85(5):2020-7.

PMID:
10843191
15.
16.

Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.

Vitti P, Chiovato L, Fiore E, Mammoli C, Rocchi R, Pinchera A.

Acta Med Austriaca. 1996;23(1-2):52-6.

PMID:
8767515
17.
18.

The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.

Islam N, Tuppal R, Hawe BS, Briones-Urbina R, Farid NR.

J Cell Biochem. 1986;31(2):107-20.

PMID:
2426288
19.

Detection of antipituitary antibodies in patients with autoimmune thyroid disease.

Nishino M, Yabe S, Murakami M, Kanda T, Kobayashi I.

Endocr J. 2001 Apr;48(2):185-91.

20.

Elevated anti-alpha-galactosyl antibody titres. A marker of progression in autoimmune thyroid disorders and in endocrine ophthalmopathy?

Etienne-Decerf J, Malaise M, Mahieu P, Winand R.

Acta Endocrinol (Copenh). 1987 May;115(1):67-74.

PMID:
2884795

Supplemental Content

Support Center